Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular abnormalities in neurofibromatosis 2

N K Ragge1, M E Baser, J Klein

  • 1Division of Ophthalmology, Childrens Hospital, Los Angeles, California, USA.

American Journal of Ophthalmology
|November 1, 1995
PubMed
Summary

Ocular abnormalities like cataracts and retinal hamartomas are common in neurofibromatosis 2. Early detection of these eye conditions in asymptomatic gene carriers can aid in the presymptomatic diagnosis of neurofibromatosis 2.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cxcl14 chemokine defines pioneer axon guidance and early circuit assembly in the inner ear.

bioRxiv : the preprint server for biology·2026
Same author

Roles for Fgf signaling during zebrafish fin regeneration.

Developmental biology·2000
Same author

Assessment of polymorphism in zebrafish mapping strains.

Genome research·1999
Same author

The mouse SCA2 gene: cDNA sequence, alternative splicing and protein expression.

Human molecular genetics·1998
Same author

Genomic structure of the human gene for spinocerebellar ataxia type 2 (SCA2) on chromosome 12q24.1.

Genomics·1998
Same author

A high-resolution PAC and BAC map of the SCA2 region.

Genomics·1997

Area of Science:

  • Ophthalmology
  • Genetics
  • Neurology

Background:

  • Neurofibromatosis 2 (NF2) is a genetic disorder.
  • Ocular manifestations are common in NF2 patients.
  • Early diagnosis is crucial for managing NF2.

Purpose of the Study:

  • To evaluate ocular abnormalities in patients with clinically diagnosed neurofibromatosis 2.
  • To assess eye conditions in asymptomatic gene carriers of NF2.
  • To identify potential early diagnostic markers for NF2.

Main Methods:

  • Cross-sectional study of 49 NF2 patients, 30 offspring, and 18 controls.
  • Comprehensive neuro-ophthalmic assessments.
  • Cranial and spinal MRI with gadolinium enhancement for at-risk individuals.

Related Experiment Videos

Main Results:

  • Posterior subcapsular/capsular or cortical cataracts were found in 67% of NF2 patients.
  • Retinal hamartomas occurred in 22% of NF2 patients.
  • Asymptomatic mutation carriers showed early signs of cataracts.

Conclusions:

  • Ocular abnormalities, including specific cataract types, are indicative of NF2.
  • Early-onset cataracts (<30 years) are suggestive of NF2.
  • Ocular findings can assist in the presymptomatic diagnosis of neurofibromatosis 2.